BHARAT IMMUNOLOGICAL & BIOLOGICALS CORPORATION
Sector : Pharmaceuticals and health care | Public Sector | Smallcap | BSE
Here's the live share price of Bharat Immunological & Biologicals Corporation along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.73₹ 0.16
As on Sep 16, 2025, 4:01 PM IST
Bharat Immunological & Biologicals Corporation Price Performance
Today's LowToday's High
₹22.01₹22.40
₹22.13
52 Weeks' Low52 Weeks' High
₹19.00₹35.88
₹22.13
Open Price
₹22.20
Prev. Close
₹21.97
Volume
13,406
Over the last 5 years, the share price of Bharat Immunological & Biologicals Corporation has declined 7.68% CAGR. Over the past year, the corresponding return has been -24.70%.
Bharat Immunological & Biologicals Corporation’s current P/E of -5.17x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Bharat Immunological & Biologicals Corporation Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Bharat Immunological & Biologicals Corporation | 0.73 | 1.51 | -10.26 | 5.33 | -24.7 | -6.18 | -7.68 |
| Sun Pharmaceutical Industries | 0.99 | -1.32 | -4.43 | -5.58 | -13.53 | 22.86 | 25.44 |
| Divi's Laboratories | 1.35 | -1.39 | -9.09 | 7.26 | 10.98 | 19.38 | 13.39 |
| Cipla | 0.28 | -0.53 | 1.92 | 4.23 | -6.24 | 14.18 | 15.63 |
| Torrent Pharmaceuticals | -2.95 | -3.25 | 7.81 | 15.5 | 2.38 | 33.75 | 19.96 |
| Dr. Reddy's Laboratories | 1.32 | 3.7 | -2.69 | 13.92 | -1.44 | 17.09 | 7.19 |
| Mankind Pharma | -0.83 | 3.97 | 8.45 | 18.23 | 4.55 | 21.72 | 12.52 |
| Zydus Lifesciences | -0.29 | 4.77 | 6.12 | 15.71 | -7.35 | 42.05 | 21.62 |
| Lupin | 4.71 | 4.15 | 2.02 | 3.02 | -8.93 | 48.04 | 14.81 |
| Abbott India | 1.23 | -4.93 | -2.02 | 2.81 | 6.44 | 20.9 | 13.41 |
| Alkem Laboratories | 3.35 | 3.02 | 13.21 | 14.4 | -13.33 | 20.01 | 14.29 |
| Aurobindo Pharma | 4.59 | 0.18 | -4.54 | -1.88 | -30.1 | 26.95 | 5.6 |
| Glenmark Pharmaceuticals | -1.88 | 5.17 | 23.41 | 45.12 | 19.22 | 77.31 | 32.95 |
| Laurus Labs | -0.79 | 3.44 | 31.66 | 53.95 | 77.42 | 20.1 | 27.14 |
| Biocon | -1.25 | -1.13 | 0.78 | 7.85 | -7.84 | 7.35 | -3.86 |
| Anthem Biosciences | 1.45 | 3.75 | 13.75 | 13.75 | 13.75 | 4.39 | 2.61 |
| GlaxoSmithKline Pharmaceuticals | -2.6 | -1.6 | -18.46 | 1.95 | -3 | 24.23 | 9.16 |
| Cohance Lifesciences | -2.9 | 10.08 | -0.45 | -12.87 | -15.54 | 28.96 | 21.52 |
| Gland Pharma | 5.31 | 2.52 | 14.26 | 30.13 | 8.35 | -4.11 | 2.12 |
| Ipca Laboratories | -0.61 | -5.32 | -3.76 | -0.34 | -10.15 | 14.97 | 3.52 |
Over the last one year, Bharat Immunological & Biologicals Corporation has declined 24.70% compared to peers like Sun Pharmaceutical Industries (-13.53%), Divi's Laboratories (10.98%), Cipla (-6.24%). From a 5 year perspective, Bharat Immunological & Biologicals Corporation has underperformed peers relative to Sun Pharmaceutical Industries (25.44%) and Divi's Laboratories (13.39%).
Bharat Immunological & Biologicals Corporation Financials
Bharat Immunological & Biologicals Corporation Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 22.06 | 21.99 |
| 10 | 22.04 | 22.03 |
| 20 | 22.11 | 22.08 |
| 50 | 22.46 | 22.47 |
| 100 | 23.46 | 23 |
| 200 | 23.67 | 23.91 |
Bharat Immunological & Biologicals Corporation Share Holding Pattern
In the latest quarter, Bharat Immunological & Biologicals Corporation remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved down to 40.74% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Bharat Immunological & Biologicals Corporation Corporate Actions
Date Time | Announcement |
|---|---|
| Aug 07, 2024, 10:28 PM IST | Bharat Immunolog - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBI |
| Feb 29, 2024, 10:27 PM IST | Bharat Immunolog - Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBI |
| Dec 13, 2023, 9:13 PM IST | Bharat Immunolog - Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Sche |
About Bharat Immunological & Biologicals Corporation
Bharat Immunological & Biologicals Corporation Ltd. is a Public Limited Listed company incorporated on 10/03/1989 and has its registered office in the State of Uttar Pradesh, India. Company's Corporate Identification Number(CIN) is L24232UP1989GOI010542 and registration number is 010542. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 44.61 Cr. and Equity Capital is Rs. 43.18 Cr. for the Year ended 31/03/2023.
- IndustryPharmaceuticals
- AddressBIBCOL, OPV Plant, Village Chola, Bulandshahar Dist Uttar Pradesh 203203
- Contact
Management
- Dr. Y K GuptaChairman
- Dr. Sanjay Kumar MishraManaging Director
- Dr. Alka SharmaDirector
- Dr. Mohd AslamDirector
- Mr. Roshan LalDirector
- Dr. Sudhanshu VratiDirector
- Dr. Madhu DikshitDirector
FAQs on Bharat Immunological & Biologicals Corporation Share Price
What is the share price of Bharat Immunological & Biologicals Corporation?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Bharat Immunological & Biologicals Corporation is ₹22.13 as on Sep 16, 2025.
What kind of stock is Bharat Immunological & Biologicals Corporation?
The Bharat Immunological & Biologicals Corporation is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Bharat Immunological & Biologicals Corporation?
The market cap of Bharat Immunological & Biologicals Corporation is ₹95.56 Cr as on Sep 16, 2025.
What are today's High and Low prices of Bharat Immunological & Biologicals Corporation?
Today’s highest and lowest price of Bharat Immunological & Biologicals Corporation are ₹22.40 and ₹22.01.
What are the 52 Week High and 52 Week Low of Bharat Immunological & Biologicals Corporation?
The 52-week high/low is the highest and lowest price at which Bharat Immunological & Biologicals Corporation stock has traded in the past 52-week or nearly a year. The 52-week high of Bharat Immunological & Biologicals Corporation is ₹35.88 and 52-week low of Bharat Immunological & Biologicals Corporation is ₹19.00 as on Sep 16, 2025.
How has the Bharat Immunological & Biologicals Corporation performed historically in terms of returns?
The Bharat Immunological & Biologicals Corporation has shown returns of 0.73% over the past day, 1.51% for the past month, -10.26% over 3 months, -24.7% over 1 year, -6.18% across 3 years, and -7.68% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Bharat Immunological & Biologicals Corporation?
P/E ratio of and PB ratio of Bharat Immunological & Biologicals Corporation are -5.17 and 1.09 on Sep 16, 2025. While the company gives a dividend yield of 0.00 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data